CLINICAL_TRIALS
ClinicalTrials.gov record update
Intra-arterially Delivered Autologous Mesenchymal Stem/Stromal Cell Therapy in Patients With Diabetic Kidney Disease: A Phase I Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03840343
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:26.456406+00:00
- Published At
- 2025-08-17T00:00:00+00:00
- Record Updated At
- 2025-08-17
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Diabetic Kidney Disease", "Diabetic Nephropathies", "Diabetes Mellitus, Type 2", "Diabetes Mellitus, Type 1", "Chronic Kidney Disease", "Diabetic Nephropathy Type 2", "Kidney Failure", "Kidney Insufficiency"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-17"- protocolSection.identificationModule.nctId
"NCT03840343"- protocolSection.identificationModule.officialTitle
"Intra-arterially Delivered Autologous Mesenchymal Stem/Stromal Cell Therapy in Patients With Diabetic Kidney Disease: A Phase I Study"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.